2,854 Agilent Technologies, Inc. $A Shares Acquired by Cardinal Capital Management

Cardinal Capital Management raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 3.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 78,054 shares of the medical research company’s stock after acquiring an additional 2,854 shares during the period. Agilent Technologies makes up approximately 1.6% of Cardinal Capital Management’s investment portfolio, making the stock its 15th largest position. Cardinal Capital Management’s holdings in Agilent Technologies were worth $13,449,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in A. Investment Research Partners LLC lifted its holdings in Agilent Technologies by 1.8% during the 3rd quarter. Investment Research Partners LLC now owns 3,646 shares of the medical research company’s stock worth $628,000 after purchasing an additional 63 shares during the last quarter. Greenleaf Trust grew its holdings in Agilent Technologies by 0.8% in the 2nd quarter. Greenleaf Trust now owns 8,117 shares of the medical research company’s stock valued at $1,078,000 after buying an additional 68 shares in the last quarter. Plan A Wealth LLC grew its holdings in Agilent Technologies by 1.9% in the 3rd quarter. Plan A Wealth LLC now owns 3,567 shares of the medical research company’s stock valued at $615,000 after buying an additional 68 shares in the last quarter. Nilsine Partners LLC grew its holdings in Agilent Technologies by 0.8% in the 2nd quarter. Nilsine Partners LLC now owns 9,650 shares of the medical research company’s stock valued at $1,282,000 after buying an additional 72 shares in the last quarter. Finally, Aspiriant LLC increased its position in Agilent Technologies by 2.0% during the 3rd quarter. Aspiriant LLC now owns 3,786 shares of the medical research company’s stock worth $652,000 after buying an additional 73 shares during the period.

Agilent Technologies Trading Up 2.8%

Shares of Agilent Technologies stock opened at $177.93 on Thursday. The company has a market capitalization of $50.16 billion, a price-to-earnings ratio of 35.03, a PEG ratio of 2.63 and a beta of 1.21. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $178.21. The firm’s 50-day moving average price is $160.50 and its two-hundred day moving average price is $138.97.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The company’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts forecast that Agilent Technologies, Inc. will post 6.20 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th will be paid a dividend of $0.2550 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, October 6th. Agilent Technologies’s payout ratio is presently 20.08%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction on Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the sale, the director owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Wall Street Analysts Forecast Growth

A has been the subject of a number of recent research reports. UBS Group started coverage on shares of Agilent Technologies in a research report on Wednesday, September 9th. They issued a “neutral” rating and a $165.00 target price for the company. JPMorgan Chase & Co. raised their price target on shares of Agilent Technologies from $180.00 to $190.00 and gave the stock an “overweight” rating in a research report on Thursday, August 27th. Sanford C. Bernstein raised their price target on shares of Agilent Technologies from $155.00 to $180.00 and gave the stock an “outperform” rating in a research report on Thursday, August 27th. Morgan Stanley lifted their price objective on shares of Agilent Technologies from $175.00 to $190.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 13th. Finally, TD Cowen increased their target price on shares of Agilent Technologies from $180.00 to $196.00 and gave the stock a “buy” rating in a research report on Tuesday, October 13th. Fifteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $173.65.

Agilent Technologies Profile

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.